PUBLISHER: The Business Research Company | PRODUCT CODE: 2127219
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127219
Automated chemotherapy preparation and infusion refer to integrated robotic hardware and closed-system transfer software platforms utilized in oncology pharmacies to accurately compound and safely administer cytotoxic cancer medications. By automating processes such as liquid handling, dilution, and labeling within a sterile enclosure, these systems reduce the risk of pre-analytical dosing errors, improve inventory management, and safeguard pharmacy personnel from direct exposure to hazardous chemical substances.
The primary product categories of automated chemotherapy preparation and infusion include automated chemotherapy compounding systems, smart infusion pumps, integrated preparation and infusion systems, and workflow management software. Automated chemotherapy compounding systems are robotic and automated platforms developed to accurately prepare cytotoxic medications while enhancing dosing accuracy, workflow efficiency, and healthcare worker safety. These solutions support chemotherapy preparation and chemotherapy infusion modalities while utilizing technologies such as fully automated robotic systems, semi-automated workstations, and artificial intelligence-enabled workflow automation. They are used with cytotoxic drug classes including alkylating agents, antimetabolites, plant alkaloids, and antitumor antibiotics and are utilized by end users including oncology clinics and centers, hospitals, specialty pharmacies, and others.
Tariffs are influencing the automated chemotherapy preparation and infusion market by increasing the cost of imported robotic compounding systems, intelligent infusion pumps, precision sensors, semiconductor components, and sterile fluid handling equipment required for automated oncology workflows. This is increasing manufacturing and procurement expenses while slowing the adoption of automated chemotherapy compounding systems, integrated preparation and infusion platforms, and workflow management software. Hardware-intensive product categories are experiencing the greatest impact, particularly across North America, Europe, and Asia-Pacific because of global supply chain reliance. However, tariffs are also promoting domestic manufacturing, regional supplier diversification, and stronger investment in local medical device and healthcare automation production, strengthening long-term market resilience.
The automated chemotherapy preparation and infusion market research report is one of a series of new reports from The Business Research Company that provides automated chemotherapy preparation and infusion market statistics, including automated chemotherapy preparation and infusion industry global market size, regional shares, competitors with a automated chemotherapy preparation and infusion market share, detailed automated chemotherapy preparation and infusion market segments, market trends and opportunities, and any further data you may need to thrive in the automated chemotherapy preparation and infusion industry. This automated chemotherapy preparation and infusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The automated chemotherapy preparation and infusion market size has grown strongly in recent years. It will grow from $1.37 billion in 2025 to $1.48 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising global cancer incidence, increasing adoption of hospital pharmacy automation, growing demand for accurate chemotherapy dosing, expanding oncology treatment infrastructure, increasing awareness of hazardous drug handling safety.
The automated chemotherapy preparation and infusion market size is expected to see strong growth in the next few years. It will grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for precision oncology workflows, growing investment in automated pharmacy infrastructure, rising adoption of personalized chemotherapy treatment, expanding outpatient cancer treatment services, increasing focus on medication traceability and regulatory compliance. Major trends in the forecast period include increasing adoption of robotic chemotherapy compounding systems, growing demand for closed system drug preparation solutions, rising focus on reducing chemotherapy medication errors, expanding implementation of sterile automated pharmacy workflows, increasing emphasis on occupational safety in oncology pharmacies.
The increasing cancer incidence is anticipated to drive the growth of the automated chemotherapy preparation and infusion market in the coming years. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells throughout the body. The rising incidence of cancer is largely attributed to the aging global population, as advancing age contributes to the accumulation of genetic mutations and prolonged exposure to cancer-related risk factors, leading to a greater prevalence of cancer. Automated chemotherapy preparation and infusion systems enhance the safety and efficiency of cancer treatment by automating drug preparation and administration, reducing medication errors, limiting healthcare worker exposure to hazardous drugs, and improving oncology workflow efficiency. For instance, in July 2026, according to the World Health Organization (WHO), a Switzerland-based health agency, annual new cancer cases reached an estimated 20.6 million worldwide, with nearly 10 million deaths, and this number is expected to increase to approximately 35 million cases by 2050. Therefore, the increasing cancer incidence is contributing to the growth of the automated chemotherapy preparation and infusion market.
Leading companies operating in the automated chemotherapy preparation and infusion market are focusing on developing advanced robotic compounding systems to improve medication accuracy, enhance workflow efficiency, and reduce healthcare workers' exposure to hazardous drugs. Robotic chemotherapy compounding systems are automated solutions that prepare chemotherapy drugs with high precision and consistency. They improve dosing accuracy, enhance workflow efficiency, and reduce healthcare workers' exposure to hazardous drugs. For example, in June 2026, Korea University Ansan Hospital, a South Korea-based healthcare organization, introduced the APOTECA Chemo robotic chemotherapy compounding system in its Department of Pharmacy. The system automates the preparation of chemotherapy medications based on individual patient prescriptions, standardizes the compounding process across treatment cycles, and minimizes healthcare workers' exposure to hazardous drugs, supporting the adoption of automated chemotherapy preparation technologies.
In June 2024, Equashield, a US-based developer of the EQUASHIELD Pro automated chemotherapy compounding robot, entered into a partnership with Pharmacy Stars to improve safety standards and regulatory adherence across healthcare operations. The collaboration combined automated hazardous drug compounding robotics with digital compliance management software to optimize chemotherapy preparation processes. As a result, it improved real-time tracking, safety validation, and record-keeping capabilities, enhancing the precision and regulatory compliance of automated oncology compounding workflows. Pharmacy Stars is a US-based provider of enterprise pharmacy compliance, regulatory management, and quality assurance software.
Major companies operating in the automated chemotherapy preparation and infusion market report are Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, ICU Medical Inc., Grifols S.A., Terumo Corporation, Omnicell Inc., Moog Inc., Nipro Corporation, Equashield LLC, Loccioni Group S.r.l., ARxIUM Inc., CODAN Medizinische Gerate GmbH, Micrel Medical Devices S.A., Yuyama Co. Ltd., Simplivia Healthcare Ltd., ACE Medical Co. Ltd., Comecer S.p.A., Fagron NV
North America was the dominant region in the automated chemotherapy preparation and infusion market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the automated chemotherapy preparation and infusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the automated chemotherapy preparation and infusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The automated chemotherapy preparation and infusion market includes revenues earned by entities by providing services such as robotic chemotherapy compounding, automated dose verification, infusion therapy management, equipment maintenance, and software integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated chemotherapy preparation and infusion market also includes sales ofautomated chemotherapy compounding systems, robotic chemotherapy preparation systems, automated drug compounding robots, closed-system transfer devices (CSTDs) and automated infusion pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automated Chemotherapy Preparation And Infusion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses automated chemotherapy preparation and infusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for automated chemotherapy preparation and infusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated chemotherapy preparation and infusion market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.